The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The goal of the IONSYS REMS is to mitigate the risk of respiratory depression resulting from accidental exposure to persons for whom it is not prescribed by:
Ensuring dispensing to patients in certified hospitals only; and
Informing healthcare providers of the serious risk of respiratory depression resulting from accidental exposure.
What do participants need to know?
Below is a general overview of the REMS for all REMS participants (e.g., patients, pharmacies, and healthcare providers). See the application holder(s) REMS Website or the approved REMS materials for more information.
Train all relevant staff involved in dispensing and administration on the REMS Program requirements.
Have all relevant staff involved in dispensing and administration successfully complete the Knowledge Assessment and submit it to the authorized represenative.
Establish processes and procedures to ensure Ionsys is not dispensed for use outside of a certified hospital.
Designate an authorized representative to carry out the certification process on behalf of the hospital.
Have the authorized representative review the Safety Brochure: Guide for Nurses and Pharmacists, Instructions for Use and Disposal, and the Medication Guide.
Have the authorized representative successfully complete the Knowledge Assessment and submit it to the REMS program.
Have the authorized representative enroll in the REMS Program by completing the Hospital Enrollment Form.
After certification, within 3 weeks
Provide relevant staff involved in prescribing, dispensing, and administration with the Dear Healthcare Provider Letters and Dear Hospital Pharmacy Letter.
To maintain certification to dispense, within 4 weeks of designating a new authorized representative
Have the authorized representative review the Safety Brochure: Guide for Nurses and Pharmacists, Instructions for Use and Disposal, and the Medication Guide.
Have the authorized representative successfully complete the Knowledge Assessment.
Have the authorized representative enroll in the REMS Program by completing the Hospital Enrollment Form.
To maintain certification to dispense, every 3 years from initial enrollment
Designate an authorized representative to carry out the certification process on behalf of the hospital.
Have the authorized representative review the Safety Brochure: Guide for Nurses and Pharmacists, Instructions for Use and Disposal, and the Medication Guide.
Have the authorized representative successfully complete the Knowledge Assessment.
Have the authorized representative enroll in the REMS Program by completing the Hospital Enrollment Form.
At all times
For new staff involved in the dispensing and administration: have successfully complete the Knowledge Assessment and submit it to the authorized representative.
Comply with audits carried out by The Medicines Company, FDA, or a third party to ensure that all processes and procedures are in place and are being followed.
Maintain appropriate documentation.
Wholesalers that distribute Ionsys must
To be able to distribute
Establish processes and procedures to ensure that the drug is distributed only to certified hospitals.
Train all relevant staff involved in distributing on the REMS program requirements.
At all times
Maintain records of distribution.
Comply with audits carried out by The Medicines Company, FDA, or a third part to ensure
What materials are included in the REMS?
The REMS includes a REMS Document. In addition, the REMS includes the following materials intended for patients and healthcare providers. For a specific Medication Guide of a product in the Ionsys REMS, see the DailyMed link(s).
This webpage provides REMS assessment plan measures, metrics, and indicators for drug and biological products with a REMS. The REMS assessment plan measures, metrics, and indicators are part of the overall REMS assessment plan used by FDA to evaluate the performance of a REMS and are included in FDA approval letters. The current REMS assessment plan measures, metrics, and indicators are extracted from regulatory letters that contain REMS information, including FDA approval letters, and posted here as they become available.
What updates have been made to the REMS?
Date
Summary of change
10/03/2018
Modified to change the timing of the audits of the certified hospitals.
03/29/2017
Modified to align to labeling approved on December 16, 2016 and make additional minor modifications in the REMS document and materials.
11/12/2015
Modified to:
Make editorial changes to the REMS document and the following REMS appended materials:Ionsys REMS Knowledge Assessment, Ionsys REMS Safety Brochure: Guide for Nurses and Pharmacists, and Ionsys REMS Hospital Enrollment Form.
Add functionality to the Ionsys REMS website that allows for Authorized Representatives, nurses, and pharmacists to log in and access educational materials and the Ionsys REMS Knowledge Assessment as well as the ability to link user accounts with the corresponding Authorized Representative.
04/30/2015
Approval of the REMS.
Disclaimer: This webpage provides general information about REMS programs
to various REMS participants (e.g., patients, pharmacies, and healthcare providers).
The summary information provided herein is not comprehensive and may not include
all of the information relevant to REMS participants. This webpage does not
constitute a replacement, modification, or revision of the approved REMS document,
including any appended REMS materials. Refer to the approved REMS document
for complete information on the REMS requirements for each approved application.